Jafron Biomedical (China) Probability of Future Stock Price Finishing Over 28.77

300529 Stock   29.86  0.52  1.71%   
Jafron Biomedical's future price is the expected price of Jafron Biomedical instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Jafron Biomedical Co performance during a given time horizon utilizing its historical volatility. Check out Jafron Biomedical Backtesting, Jafron Biomedical Valuation, Jafron Biomedical Correlation, Jafron Biomedical Hype Analysis, Jafron Biomedical Volatility, Jafron Biomedical History as well as Jafron Biomedical Performance.
  
Please specify Jafron Biomedical's target price for which you would like Jafron Biomedical odds to be computed.

Jafron Biomedical Target Price Odds to finish over 28.77

The tendency of Jafron Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above  28.77  in 90 days
 29.86 90 days 28.77 
about 56.23
Based on a normal probability distribution, the odds of Jafron Biomedical to stay above  28.77  in 90 days from now is about 56.23 (This Jafron Biomedical Co probability density function shows the probability of Jafron Stock to fall within a particular range of prices over 90 days) . Probability of Jafron Biomedical price to stay between  28.77  and its current price of 29.86 at the end of the 90-day period is about 12.34 .
Assuming the 90 days trading horizon Jafron Biomedical has a beta of 0.3. This suggests as returns on the market go up, Jafron Biomedical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Jafron Biomedical Co will be expected to be much smaller as well. Additionally Jafron Biomedical Co has an alpha of 0.3178, implying that it can generate a 0.32 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Jafron Biomedical Price Density   
       Price  

Predictive Modules for Jafron Biomedical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Jafron Biomedical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
25.8029.8633.92
Details
Intrinsic
Valuation
LowRealHigh
26.4530.5034.57
Details
Naive
Forecast
LowNextHigh
25.2429.3033.36
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Jafron Biomedical. Your research has to be compared to or analyzed against Jafron Biomedical's peers to derive any actionable benefits. When done correctly, Jafron Biomedical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Jafron Biomedical.

Jafron Biomedical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Jafron Biomedical is not an exception. The market had few large corrections towards the Jafron Biomedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Jafron Biomedical Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Jafron Biomedical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.32
β
Beta against Dow Jones0.30
σ
Overall volatility
3.51
Ir
Information ratio 0.06

Jafron Biomedical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Jafron Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Jafron Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Jafron Biomedical had very high historical volatility over the last 90 days
Jafron Biomedical is unlikely to experience financial distress in the next 2 years
About 51.0% of the company shares are owned by insiders or employees
Latest headline from news.google.com: Jafron BiomedicalLtd Seems To Use Debt Rather Sparingly - Simply Wall St

Jafron Biomedical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Jafron Stock often depends not only on the future outlook of the current and potential Jafron Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Jafron Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding807.6 M

Jafron Biomedical Technical Analysis

Jafron Biomedical's future price can be derived by breaking down and analyzing its technical indicators over time. Jafron Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Jafron Biomedical Co. In general, you should focus on analyzing Jafron Stock price patterns and their correlations with different microeconomic environments and drivers.

Jafron Biomedical Predictive Forecast Models

Jafron Biomedical's time-series forecasting models is one of many Jafron Biomedical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Jafron Biomedical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Jafron Biomedical

Checking the ongoing alerts about Jafron Biomedical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Jafron Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Jafron Biomedical had very high historical volatility over the last 90 days
Jafron Biomedical is unlikely to experience financial distress in the next 2 years
About 51.0% of the company shares are owned by insiders or employees
Latest headline from news.google.com: Jafron BiomedicalLtd Seems To Use Debt Rather Sparingly - Simply Wall St

Other Information on Investing in Jafron Stock

Jafron Biomedical financial ratios help investors to determine whether Jafron Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jafron with respect to the benefits of owning Jafron Biomedical security.